Nodding Syndrome Unknown Status Phase 2 Trials for Pyridoxine (DB00165)

IndicationStatusPhase
DBCOND0003622 (Nodding Syndrome)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01730313Treatment of Nodding Syndrome - A Randomized Blinded Placebo-Controlled Crossover Trial of Oral Pyridoxine and Conventional Anti-Epileptic Therapy, in Northern Uganda — 2012Treatment